Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 15, 2021
Aragen Life Sciences, a global research, development, and manufacturing solutions provider (CRO/CDMO), has signed a definitive agreement to acquire Pune-based Intox Pvt. Ltd. This acquisition will expand Aragen’s end-to-end integrated discovery and ...
read more
Aragen announced two senior level appointments. Dr. Manjunath Ramarao has been appointed as the Chief Scientific Officer (CSO) and Executive Vice President, Integrated Drug Discovery (IDD) and will be based in the USA. Jayadeva Sajankila has been ...
read more
Thursday, October 19, 2023
Aragen, a leading provider of contract research, development, and manufacturing services for the pharmaceutical, biotechnology, agrochemicals, and animal health sectors, has inaugurated its advanced formulations manufacturing facility in Hyderabad, ...
read more
Aragen Life Sciences announced an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.
read more
Wednesday, April 15, 2026
Aragen has launched ChemiSHE, a first-of-its-kind chemistry synthesis laboratory in India, entirely operated and led by women scientists. The lab was inaugurated on 8 April 2026 at Aragen’s Mallapur campus in Hyderabad.
read more
Thursday, August 07, 2025
Aragen announced the appointment of Aniel Khubchandani as CEO of its Development & Manufacturing Solutions business. Aniel will be a member of Aragen’s Management Council and will be based in Hyderabad.
read more
Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it has operationalized the first phase of its biologics manufacturing facility in Bangalore, India through its 100% ...
read more
Aragen Life Sciences (formerly, GVK BIO), a leading Contract Research and Development Organization (CRDO), headquartered out of Hyderabad, India, announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small ...
read more
Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it was setting up a new biologics manufacturing facility in Bangalore, India.
read more
Thursday, October 20, 2022
Aragen announced that it will operationalize its formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023. The 12,000 square feet new facility will strengthen the company’s ability to deliver clinical supplies to ...
read more
Aragen Life Sciences, formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked its transition to a new brand identity. With a legacy of over 20 years of partnering with innovator...
read more
Friday, February 24, 2017
Aramark is increasing its capacity to provide cleanroom services to customers throughout the Southwest with its new 34,350 square foot processing plant in McKinney, Texas.
read more
Thursday, December 19, 2024
Aramis Biotechnologies Inc. and Biodextris Inc. announced a strategic partnership that will leverage the expertise of both companies to ensure efficient downstream manufacturing of clinical materials for Aramis' leading product candidate, a seasonal ...
read more
Thursday, November 14, 2024
Aravax announced it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more